← Leaderboards
Ching Yuan
University Of Minnesota
$1,012,410
Attributed
$1,466,703
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $342K · FY2007–12$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,466,703 · 3
By mechanism
R21$785,263 · 2
R43$681,440 · 1
Top collaborators
- James N Herron2 shared
- Alan Wei2 shared
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventSignal TransductionCellsLabelMediatingResearch StudyCorneal DystrophyDosageGenesKineticsAntibodiesPeptidesRecurrenceReporterEpithelialCorneaAnimal ModelDepositionFluorescenceFoundationsInflammationKeratoplastyLinkTissues
Grant awards (6)
Novel Method and Self Contained System for Reliable Assessment of Potency of Botu$339,440
R43 · FY2012 · NS
Novel Method and Self Contained System for Reliable Assessment of Potency of Botu$342,000
R43 · FY2011 · NS
Smad3 inhibitors for ophthalmic applications$226,500
R21 · FY2010 · EY · contact PI
Smad3 inhibitors for ophthalmic applications$188,750
R21 · FY2009 · EY · contact PI
Treatment of BIGH3-related Corneal Dystrophies with Meptides$183,138
R21 · FY2008 · EY · contact PI
Treatment of BIGH3-related Corneal Dystrophies with Meptides$186,875
R21 · FY2007 · EY · contact PI